Home / News / Detail
At the beginning of 2020, novel Coronavirus infection swept the world. Faced with the severe situation of virus spread, Deepblue medical research and development team made a quick decision, COVID-19 (Sars-CoV-2) IgG/IgM Ab test kit (Colloidal gold) was successfully developed on February 2020 to contribute to the prevention and control of COVID-19. The results were released at the press conference on the eradication of COVID-19 cases in Anhui Province.
Since March 2020, the International Trade Department of DeepBlue has been working overtime to actively assist foreign customers in product registration, so as to ensure the fastest speed to help screen infected patients and reduce the spread of the virus. For now, the COVID-19 (Sars-CoV-2) IgG/IgM Ab test kit (Colloidal gold) that manufactured by Deepblue Medical has been successively registered in 20 countries, for example:
At the same time, the new product COVID-19 Antigen Rapid Test Kit
Deepblue COVID-19 (Sars-CoV-2) IgG/IgM Ab test kit (Colloidal gold) has been recognized by many overseas countries in a short time. This proud achievement is the result of the joint efforts of Deepblue family. We would like to thank the Deepblue family for their great contributions during the epidemic prevention and control period.
© Copyright 2018 Anhui Deep Blue Medical Technology Co., Ltd